Pembelian
Does a Trader really think ECYT will gain 50% in a Month
Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases. one one to see how much a stock can move is to look at the ATM Straddle to get two Measured Move Targets. The ECYT ATM April 15 Straddle is priced at $6.80 implying the stock can move to either $21.80 or $9.20 by april expiration. Obviously, by the high implied volatility we can tell that their will be a drug announcement in April. One trader thinks the stock can move to $23.25 as we saw a trader buy ECYt april 22.5 calls for $.75.
Their Risk: $75 per 1 lot
Their Reward; Unlimited
Their Breakeven; $23.25
Their Risk: $75 per 1 lot
Their Reward; Unlimited
Their Breakeven; $23.25
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.